Oman Pharmaceuticals & Healthcare Q1 2021

Oman Pharmaceuticals & Healthcare Q1 2021

Key View:

Oman's economy will contract in 2020 amid the effects of the sharp drop in oil prices and the Covid-19 pandemic. Thiswill mean further price revisions and continued tight scrutiny of the pharmaceutical industry to ensure the government's healthspending yields the best value for money possible, while still providing a good service across the country. A high burden of chronicdiseases and alignment of regulations with the rest of the Gulf Cooperation Council countries will provide a little alleviation from thedrawback of Oman's small market size while the country is also moving ahead with a number of agreements with internationalpartners to help develop its health sector. Meanwhile, the planned investment of OMR497mn into a new Medical City in Muscat, aspart of the government's economic expansion plan, should help encourage an increase in private sector investment into the sector.


Key View
Oman Pharmaceutical & Healthcare Covid-19 Impact
SWOT
Industry Forecast
Pharmaceutical Market Forecast
Healthcare Market Forecast
Prescription Drug Market Forecast
Patented Drug Market Forecast
Generic Drug Market Forecast
OTC Medicine Market Forecast
Pharmaceutical Trade Forecast
Industry Risk/Reward Index
Middle East And North Africa Pharmaceuticals Market Presents A Diverse Mix Of Opportunities
Oman Innovative Pharmaceuticals Risk/Reward Index
Regulatory Development
Regulatory Review
Market Overview
Competitive Landscape
Company Profile
National Pharmaceutical Industries
Zynova/Oman Pharmaceutical Products Company
Oman Demographic Outlook
Pharmaceuticals & Healthcare Glossary
Pharmaceuticals & Healthcare Methodology

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook